
北美生物可吸收聚合物市场预测至 2028 年 - COVID-19 影响和区域分析(按类型 [聚乳酸 (PLA)、聚乙醇酸 (PGA)、聚二氧环己酮、聚己内酯 (PCL) 等] 和应用(骨科器械、药物输送、和别的)
No. of Pages: 95 | Report Code: TIPRE00028630 | Category: Chemicals and Materials
No. of Pages: 95 | Report Code: TIPRE00028630 | Category: Chemicals and Materials
生物可吸收医疗器械的需求植入物和伤口敷料覆盖物由于其在人体内的自溶解特性而不断增加。生物可吸收聚合物,如聚乳酸、聚己内酯和聚二氧环己酮,广泛用于制造螺钉、销、杆、板、支架、缝合线、支架和其他医疗植入装置。此外,这些聚合物还用作人体内的受控药物释放植入物。一旦患者康复,当器官开始发育时,这些植入物逐渐开始溶解,并在完成其功能后被身体完全吸收。由于身体本身会吸收这些生物可吸收植入物,因此患者不需要第二次手术干预来移除它们。因此,与这些植入物相关的临床结果和成本效益的改善正在支持市场的增长。此外,由于生物可吸收聚合物在伤口处理方面的应用不断增加,其需求也出现激增。基于生物可吸收的合成聚合物包裹物广泛用于伤口敷料和覆盖,因为它们提供了防止细菌渗透以及伤口氧气渗透性的屏障。该聚合物还用于制造可生物吸收的包裹物和片材,这些包裹物和片材是极薄且透明的箔片,能够将组织块固定到位并促进术后愈合。此外,生物可吸收聚合物粉末还用于真皮填充剂应用。真皮填充剂也称为软组织填充剂,通过小手术将其注射到皮肤中,以丰盈薄唇、增强浅层轮廓、软化面部皱纹、消除皱纹并改善疤痕外观。
美国报告的 COVID-19 病例数是北美所有主要国家中最高的,这阻碍了该地区的制造流程、研究和开发活动。其他生产单位的关闭阻碍了生物可吸收聚合物市场。疫情期间医疗器械生产的停顿和非必要手术的延误也阻碍了 2020 年的市场增长。《骨与关节外科杂志》2020 年 5 月的一项关于骨科手术量的研究表明,美国预计到 2022 年中期,关节和脊柱手术的累积积压将超过 100 万例,这将限制医疗植入物的需求。然而,放松封锁后生产设施的重新开放有助于生物可吸收聚合物市场活动的复苏。
凭借新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动北美生物可吸收聚合物市场实现良好的复合年增长率。
北美生物可吸收聚合物市场细分
Strategic insights for North America Bioresorbable Polymers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,189.92 Million |
Market Size by 2028 | US$ 2,499.56 Million |
Global CAGR (2021 - 2028) | 11.2% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Bioresorbable Polymers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Bioresorbable Polymers Market is valued at US$ 1,189.92 Million in 2021, it is projected to reach US$ 2,499.56 Million by 2028.
As per our report North America Bioresorbable Polymers Market, the market size is valued at US$ 1,189.92 Million in 2021, projecting it to reach US$ 2,499.56 Million by 2028. This translates to a CAGR of approximately 11.2% during the forecast period.
The North America Bioresorbable Polymers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Bioresorbable Polymers Market report:
The North America Bioresorbable Polymers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Bioresorbable Polymers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Bioresorbable Polymers Market value chain can benefit from the information contained in a comprehensive market report.